Hannah Joseph Hospital IPO Subscription Closes With Moderate Demand

The initial public offering (IPO) of Hannah Joseph Hospital is drawing to a close today, Wednesday, January 28, 2026, marking the end of its three-day subscription period that began on Thursday, January 22, 2026. The IPO has been subscribed ~1.32 times, a sign of moderate investor interest as bidding concludes.

Subscription and Investor Response
• The IPO received bids for 5.7 million shares against 4.29 million shares on offer as of late morning data.
• Non-Institutional Investors (NIIs) led the demand with a subscription of 1.60 times, while retail individual investors contributed a 1.44 times subscription.
• The portion reserved for Qualified Institutional Buyers (QIBs) saw lower interest, being subscribed to 88%.

IPO Pricing and Investment Details
• The public issue is entirely a fresh issue of 6 million equity shares aggregating to around ₹42 crore. There is no offer-for-sale component.
• The IPO price band was fixed at ₹67 to ₹70 per share, with a lot size of 2,000 shares.
• At the upper price band, a retail investor would need roughly ₹2,80,000 to apply for two lots (4,000 shares).

Grey Market and Expected Allotment Timeline
• In the grey market, unlisted shares of Hannah Joseph Hospital were trading flat at ₹70, which is the upper end of the price band, suggesting neutral sentiment on listing gains.
• As the IPO subscription ends today, the **basis of allotment is likely to be finalised on Thursday, January 29, 2026.
• Shares are expected to be credited to investors’ demat accounts on **Friday, January 30, 2026, with a **tentative listing on the BSE SME platform on **Sunday, February 1, 2026.

Company and IPO Use of Proceeds
• Hannah Joseph Hospital operates a 150-bed multi-speciality hospital in Madurai, offering services across neurology, cardiology, psychiatry and trauma care.
• According to disclosures, net proceeds from the IPO are planned to be used for establishing a Radiation Oncology Centre and for general corporate purposes.